ABC
1Main
2BrandARO-APOC3
3MOAApolipoprotein C-III
4IndicationFamilial Hypertrigliceridemia
5Clinical Trials
6Phase IIb "SHASTA-2" severe hypertriglyceridemia
7
8Phase III "PALISADE" - NCT05089084